95 related articles for article (PubMed ID: 12532851)
1. [A design of a novel compound S-nitrosocaptopril possessing the capacities of both angiotensin converting enzyme inhibitors and NO donors].
Jia L
Sheng Li Ke Xue Jin Zhan; 1999 Jan; 30(1):53-6. PubMed ID: 12532851
[No Abstract] [Full Text] [Related]
2. The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats.
Jia L; Blantz RC
Eur J Pharmacol; 1998 Jul; 354(1):33-41. PubMed ID: 9726628
[TBL] [Abstract][Full Text] [Related]
3. Captopril and S-nitrosocaptopril as potent radiosensitizers: Comparative study and underlying mechanisms.
Jordan BF; Peeterbroeck J; Karroum O; Diepart C; Magat J; Grégoire V; Gallez B
Cancer Lett; 2010 Jul; 293(2):213-9. PubMed ID: 20144849
[TBL] [Abstract][Full Text] [Related]
4. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
[TBL] [Abstract][Full Text] [Related]
5. S-nitrosocaptopril. II. Effects on vascular reactivity.
Cooke JP; Andon N; Loscalzo J
J Pharmacol Exp Ther; 1989 Jun; 249(3):730-4. PubMed ID: 2659777
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic effects of S-nitrosocaptopril crystals as a nitric oxide donor.
Jia L; Wu CC; Guo W; Young X
Eur J Pharmacol; 2000 Mar; 391(1-2):137-44. PubMed ID: 10720645
[TBL] [Abstract][Full Text] [Related]
7. Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure.
Kotikoski H; Kankuri E; Vapaatalo H
Med Sci Monit; 2003 Jan; 9(1):BR1-7. PubMed ID: 12552230
[TBL] [Abstract][Full Text] [Related]
8. The effects of S-nitrosocaptopril on canine coronary circulation.
Nakae I; Takahashi M; Kinoshita T; Matsumoto T; Kinoshita M
J Pharmacol Exp Ther; 1995 Jul; 274(1):40-6. PubMed ID: 7616425
[TBL] [Abstract][Full Text] [Related]
9. Dual role of S-nitrosocaptopril as an inhibitor of angiotensin-converting enzyme and a nitroso group carrier.
Park JW
Biochem Biophys Res Commun; 1992 Nov; 189(1):206-10. PubMed ID: 1449475
[TBL] [Abstract][Full Text] [Related]
10. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
Resende AC; Pimentel AM; de Moura RS
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389
[TBL] [Abstract][Full Text] [Related]
11. S-nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets.
Loscalzo J; Smick D; Andon N; Cooke J
J Pharmacol Exp Ther; 1989 Jun; 249(3):726-9. PubMed ID: 2659776
[TBL] [Abstract][Full Text] [Related]
12. Optimization of S-Nitrosocaptopril Monohydrate Storage Conditions Based on Response Surface Method.
Huang L; Zhou Y; Wang Y; Lin M
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946614
[TBL] [Abstract][Full Text] [Related]
13. A novel S-nitrosocaptopril monohydrate for pulmonary arterial hypertension: H
Zhou Y; Lin M; Wang J; Chen F; Li F; Chen W; Han L; Wang C; Chen J; Shao JW; Jia L
Free Radic Biol Med; 2018 Dec; 129():107-115. PubMed ID: 30227269
[TBL] [Abstract][Full Text] [Related]
14. Acute and subacute toxicity and efficacy of S-nitrosylated captopril, an ACE inhibitor possessing nitric oxide activities.
Jia L; Pei R; Lin M; Yang X
Food Chem Toxicol; 2001 Dec; 39(12):1135-43. PubMed ID: 11696388
[TBL] [Abstract][Full Text] [Related]
15. S-nitrosocaptopril formation in aqueous acid and basic medium. A vasodilator and angiotensin converting enzyme inhibitor.
Sexto A; Iglesias E
Org Biomol Chem; 2011 Oct; 9(20):7207-16. PubMed ID: 21860877
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
[TBL] [Abstract][Full Text] [Related]
17. Physicochemistry, pharmacokinetics, and pharmacodynamics of S-nitrosocaptopril crystals, a new nitric oxide donor.
Jia L; Young X; Guo W
J Pharm Sci; 1999 Oct; 88(10):981-6. PubMed ID: 10514343
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II inhibition during myocardial ischemia-reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction.
de Gusmão FM; Becker C; Carvalho MH; Barros LF
Int J Cardiol; 2005 Apr; 100(3):363-70. PubMed ID: 15837077
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of ouabain on the vasodilator actions of nitric oxide and S-nitrosothiols in vivo: relevance to the identity of EDRF/EDHF.
Lewis SJ; Travis MD; Hashmi-Hill MP; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Dec; 45(6):383-94. PubMed ID: 16861050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
